Conference Description
The Basic Mechanisms to Clinical Trials in Brain Tumors GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by February 25, 2023. Please check back for updates.
Neuropathology, Neurosurgery, and Health Disparities
Discussion Leaders
-
Priscilla Brastianos (Massachusetts General Hospital, United States)
-
Patrick Wen (Dana Farber Cancer Institute, United States)
Speakers
-
Charles Eberhart (Johns Hopkins University, United States)
-
Nduka Amankulor (U. Penn, United States)
-
Melissa Bondy (Stanford School of Medicine, United States)
Developmental Biology of the Brain and Cancer
Discussion Leaders
-
Martine Roussel (St. Jude Children's Research Hospital, United States)
-
Charles Eberhart (Johns Hopkins University, United States)
Speakers
-
Michael Taylor (The Hospital for Sick Children, Canada)
-
Mariella Filbin (Dana-Farber Cancer Institute/Boston Children's Hospital, United States)
-
Peter Dirks (Hospital for Sick Children, University of Toronto, Canada)
-
Hongjun Song (University of Pennsylvania, United States)
-
Frank Winkler (German Cancer Research Center, Germany)
Meningioma, Brain Metastasis and Diffuse Intrinsic Pontine Glioma
Discussion Leaders
-
Mariella Filbin (Dana-Farber Cancer Institute/Boston Children's Hospital, United States)
-
Nduka Amankulor (U. Penn, United States)
Speakers
-
Priscilla Brastianos (Massachusetts General Hospital, United States)
-
Benjamin Izar (Columbia University, Vagelos College of Physicians and Surgeons, United States)
-
Suzanne Baker (St. Jude Children's Research Hospital, United States)
Genomics and Tumor Microenvironment
Discussion Leaders
-
Peter Dirks (Hospital for Sick Children, University of Toronto, Canada)
-
Michael Taylor (The Hospital for Sick Children, Canada)
Speakers
-
Mario Suva (Mass General Hospital / Harvard Medical School, United States)
-
Antonio Iavarone (University of Miami Miller School of Medicine, United States)
-
Rakesh Jain (Harvard Medical School / Massachusetts General Hospital, United States)
-
Candece Gladson (Cleveland Clinic, United States)
Mechanisms
Discussion Leaders
-
Candece Gladson (Cleveland Clinic, United States)
-
Suzanne Baker (St. Jude Children's Research Hospital, United States)
Speakers
-
Vidya Gopalakrishnan (University of Texas MD Anderson Cancer Center, United States)
-
Anna Lasorella (University of Miami, Miller School of Medicine, United States)
Immunotherapy
Discussion Leaders
-
Rakesh Jain (Harvard Medical School / Massachusetts General Hospital, United States)
-
E. Antonio Chiocca (Brigham and Women's Hospital, United States)
Speakers
-
Duane Mitchell (University of Florida, United States)
-
Kai Wucherpfennig (Dana-Farber Cancer Institute, United States)
Virus-Mediated Therapeutics
Discussion Leaders
-
Duane Mitchell (University of Florida, United States)
Speakers
-
E. Antonio Chiocca (Brigham and Women's Hospital, United States)
-
Frederick F. Lang (University of Texas MD Anderson Cancer Center, United States)
Preclinical Modeling, Gene-Fusion and Mechanism-Based Therapeutics
Discussion Leaders
-
Frank Winkler (German Cancer Research Center, Germany)
-
Antonio Iavarone (University of Miami Miller School of Medicine, United States)
Speakers
-
Taran Gujral (Fred Hutchinson Cancer Center, United States)
-
Frank Furnari (UC San Diego, United States)
-
Martine Roussel (St. Jude Children's Research Hospital, United States)
-
Frank Szulzewsky (Fred Hutchinson Cancer Center, United States)
Clinical Trials
Discussion Leaders
-
Frederick F. Lang (University of Texas MD Anderson Cancer Center, United States)
-
Kai Wucherpfennig (Dana-Farber Cancer Institute, United States)
Speakers
-
Patrick Wen (Dana Farber Cancer Institute, United States)
-
Marta Alonso (University Hospital of Navarra/ CIMA, Spain)
The GRC Power Hourâ„¢
Organizers
-
Melissa Bondy (Stanford School of Medicine, United States)
-
Vidya Gopalakrishnan (University of Texas MD Anderson Cancer Center, United States)
-
Anna Lasorella (University of Miami, Miller School of Medicine, United States)